(Q47285574)

English

Local application of recombinant active-site inhibited human clotting factor VIIa reduces thrombus weight and improves patency in a rabbit venous thrombosis model

scientific article published in June 1998

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

13 January 2018

http://europepmc.org/abstract/MED/9659887

Local application of recombinant active-site inhibited human clotting factor VIIa reduces thrombus weight and improves patency in a rabbit venous thrombosis model (English)

1 reference

Europe PubMed Central

13 January 2018

http://europepmc.org/abstract/MED/9659887

1 reference

based on heuristic

inferred from title

author name string

Holst J

1

1 reference

Europe PubMed Central

13 January 2018

http://europepmc.org/abstract/MED/9659887

Kristensen AT

2

1 reference

Europe PubMed Central

13 January 2018

http://europepmc.org/abstract/MED/9659887

Kristensen HI

3

1 reference

Europe PubMed Central

13 January 2018

http://europepmc.org/abstract/MED/9659887

Ezban M

4

1 reference

Europe PubMed Central

13 January 2018

http://europepmc.org/abstract/MED/9659887

Hedner U

5

1 reference

Europe PubMed Central

13 January 2018

http://europepmc.org/abstract/MED/9659887

publication date

1 June 1998

1 reference

Europe PubMed Central

13 January 2018

http://europepmc.org/abstract/MED/9659887

European Journal of Vascular and Endovascular Surgery

1 reference

Europe PubMed Central

13 January 2018

http://europepmc.org/abstract/MED/9659887

15

1 reference

Europe PubMed Central

13 January 2018

http://europepmc.org/abstract/MED/9659887

6

1 reference

Europe PubMed Central

13 January 2018

http://europepmc.org/abstract/MED/9659887

515-520

1 reference

Europe PubMed Central

13 January 2018

http://europepmc.org/abstract/MED/9659887

Regulation of the extrinsic pathway system in health and disease: the role of factor VIIa and tissue factor pathway inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS1078-5884%2898%2980112-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Cell biology of tissue factor, the principal initiator of blood coagulation

1 reference

https://api.crossref.org/works/10.1016%2FS1078-5884%2898%2980112-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Relative roles of tissue factor pathway inhibitor and antithrombin in the control of thrombogenesis.

1 reference

https://api.crossref.org/works/10.1016%2FS1078-5884%2898%2980112-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Hirudin in acute myocardial infarction. Safety report from the Thrombolysis and Thrombin Inhibition in Myocardial Infarction (TIMI) 9A Trial

1 reference

https://api.crossref.org/works/10.1016%2FS1078-5884%2898%2980112-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Influence of Blockade at Specific Levels of the Coagulation Cascade on Restenosis in a Rabbit Atherosclerotic Femoral Artery Injury Model

1 reference

https://api.crossref.org/works/10.1016%2FS1078-5884%2898%2980112-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Active site-blocked factors VIIa and IXa differentially inhibit fibrin formation in a human ex vivo thrombosis model

1 reference

https://api.crossref.org/works/10.1016%2FS1078-5884%2898%2980112-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevention of experimental arterial thrombosis by topical administration of active site-inactivated factor VIIa

1 reference

https://api.crossref.org/works/10.1016%2FS1078-5884%2898%2980112-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Amino acid sequence and posttranslational modifications of human factor VIIa from plasma and transfected baby hamster kidney cells

1 reference

https://api.crossref.org/works/10.1016%2FS1078-5884%2898%2980112-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Incorporation of an active site inhibitor in factor VIIa alters the affinity for tissue factor

1 reference

https://api.crossref.org/works/10.1016%2FS1078-5884%2898%2980112-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacokinetics and delayed experimental anti-thrombotic effect of two domain non-glycosylated tissue factor pathway inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS1078-5884%2898%2980112-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Consequences of reocclusion after successful reperfusion therapy in acute myocardial infarction. TAMI Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1078-5884%2898%2980112-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S1078-5884(98)80112-3

1 reference

Europe PubMed Central

13 January 2018

http://europepmc.org/abstract/MED/9659887

1 reference

Europe PubMed Central

13 January 2018

http://europepmc.org/abstract/MED/9659887

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47285574&oldid=2150358293"